Prostate cancer incidence witnessed a steep rise in the 1990s in different countries, something that is attributed to the use of prostate-specific antigen (PSA) and thus viewed as an increase in detection [2, 3]. This evidence concerns the gene KLK3 and Familial prostate cancer.